Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Rhone-Poulenc Rorer's Estalis approved in 12 E.U. countries

Oct. 13, 1998

Early clinical study results published for Organon antiprogestagen

Oct. 9, 1998

HMR presents new bile acid uptake inhibitors for hyperlipidemic disorders

Oct. 9, 1998

Vitronectin receptor antagonists from HMR particularly useful as bone resorption inhibitors

Oct. 9, 1998

Actonel now available for treatment of Paget's disease

Oct. 8, 1998

ZK-137316: chronic, low-dose regimen prevents pregnancy in monkeys with little cycle disruption

Oct. 8, 1998

New series of beta-agonists in early development at Yamanouchi

Oct. 8, 1998

Data suggest Ossigel significantly accelerates fracture healing

Oct. 7, 1998

Cell Genesys receives milestone payment from HMR for GA-EPO agreement

Oct. 7, 1998

Osiris begins clinical trials with hMSC product in cancer patients

Oct. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...